Discover why Gladstone Land Corporation's rapid growth has led to challenges despite offering a 5.8% yield. Click for more on ...

Total prescriptions and net product sales for Fanapt increased by 14% year-over-year, with new patient starts growing threefold. Vanda has expanded its psychiatry sales force to approximately 300 ...

QuidelOrtho's Q1 2025 earnings highlight strong growth in labs and flu-related sales, cost savings boosting margins, and confidence in hitting ...

Discover B&G Foods’ Q1 2025 earnings insights, challenges, and revised guidance. Explore strategic shifts, cost-saving plans, and key market trends.

IonQ’s Q1 2025 highlights growth in quantum computing with strategic acquisitions & a $22M system sale. Learn about revenue forecasts & scaling challenges.

Crude futures fell as concerns about rising OPEC+ production that had dragged down oil earlier this week outweighed positive signs of U.S.-China trade talks and a draw in U.S. crude stocks.

This quarter, Baillie Gifford’s 13F portfolio value decreased from ~$130B to ~$115B. The top three holdings are at ~17% while ...

Cryoport, Inc. (CYRX) reports strong Q1 2025 with 10% revenue growth, strategic DHL partnership, and robust cell & gene therapy advancements.

Materialise's Q1 results beat low expectations, driven by its strong Medical segment. Discover why its growth potential ...

Rigel Pharmaceuticals, Inc.'s 68% YoY revenue growth signals durable stock potential. Click for my RIGL earnings update and a ...

Discover insights from Delek US Holdings' Q1 2025 earnings call, highlighting operational improvements, $120M cash flow targets, and robust growth in ...